Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Business Briefs

Business briefs: Actavis, Bayer, Oramed, Elan

May 20, 2013

Actavis buys Warner Chilcott, FDA clears oral insulin for testing, Elan swallows AOP Orphan for $340M
 

Business briefs: Pfizer, BMS, CMS, Sanofi

May 16, 2013

Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor.
 

Business briefs: Bayer, FDA, Ranbaxy

May 15, 2013

Bayer's prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations
 

Business briefs: Angelina Jolie, adherence, Sanofi, Teva, AbbVie

May 14, 2013

Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves
 

Business briefs: Eli Lilly, Millennium/Takeda, Elan

May 13, 2013

Eli Lilly nixes one trial and fails another; Millennium is folded into Takeda, Dunsire retires; Elan pays for Theravance royalties in attempt to avoid takeover.
 

Business Briefs Merck, GSK, Novo, Walgreen, Epocrates, Doximity

May 09, 2013

HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets.
 

Business briefs: Arena, Takeda, Teva, Cubist

May 08, 2013

Arena gets closer to the market place, Takeda scoops up privately held Inviragen, Plan B court decision is coming and Cubist antibotic lands breakthrough therapy status.
 

Business briefs: Baxter; Eli Lilly; CDHPs and Statins

May 07, 2013

Baxter's Alzheimer's treatment is out of the running; Eli Lilly has upped its layoffs; insured consumers are spending less on healthcare; stains and prostate cancer may have an amicable relationship; doctors aren't screening teens for HIV.
 

Business briefs: Pfizer and CVS; the EMA; Digitas Health New York

May 06, 2013

Pfizer's online Viagra deal with CVS; reorg at the EMA; Mills moves up at Digitas
 

Business briefs: Sanofi, Allergan, Otsuka, Genmab, NIH, Novartis, DOJ

May 02, 2013

Lantus cushions Sanofi's quarterly sales; Allergan holds back on Eylea competitor; FDA limits use of Otsuka drug; Genmab lands Breakthrough label; NIH finds a link among cancers; and Novartis offers lunch with a side of medical information; DOJ appeals Plan-B Ruling.
 

Business Briefs: Teva; Vertex; CSL Behring; Boehringer; Mylan; Amgen

May 01, 2013

FDA lowers Teva's Plan B age limit to 15; CSL Behring's anticoagulant gets approval; Pradaxa gets slapped with black box for stroke risks; Mylan recruits former FDA deputy comissioner; Amgen's Neulasta and Neupogen drugs could save you in a nuclear apocalypse.
 

Business Briefs: Manhattan Research, KPMG, Scioderm and GSK

April 30, 2013

Health-seeking consumers continue social-media push; Scioderm scores FDA's "Breakthrough" designation for bullosa agent; and GSK files NDA for airway treatment.
 

Business briefs: Merck and Pfizer; Valeant and Actavis; Bayer; Gilead

April 29, 2013

Merck and Pfizer partner up for an SGLT2 for diabetes; Bayer acquires contraceptive maker; Valeant and Actavis merger negotiations are put on hold; Gilead's HIV combo drug receives regulator setback.
 

Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset

April 25, 2013

Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
 

Business Briefs: Merck, CMS and Sucampo

April 24, 2013

Merck's experimental skin cancer drug gets breakthrough status; Tavenner's nod hits a roadblock; study shows biotechs aren't doing enough to please payers; and Sucampo's Amitiza gains a new indication.
 

Business briefs: Roche, Doximity and Bayer

April 23, 2013

Roche is shuttering a division and eliminating 170 jobs; Doximity has added another client; a cautiously-worded study indicates antidepressants may be linked to autism; and NICE has endorsed a new use for Bayer's Xarelto.
 

Business Briefs: GSK, Astellas, Vertex and Orexigen

April 22, 2013

GSK and Astellas kick off the race for a new anemia treatment; Orexigen's CEO joins PhRMA; BMS and Merck team up in a hep.-C clinical trial; Novartis lands glaucoma approval; Ireland starts naming preferred drugs; Novo has new New Jersey digs; Vertex releases promising data for new cystic fibrosis treatment.
 

Business Briefs: AstraZeneca, Amgen, BMS and Merck

April 18, 2013

AstraZeneca cuts a deal with OCB to test unnamed cancer drug; an Enbrel biosimilar launches in India; BMS and Santaris seal an mRNA tech deal; Merck expands its China presence; Alzheimer's advocacy group parents a spin-off.
 

Business Briefs: Amgen, Allergan, Eli Lilly, DePuy

April 17, 2013

Amgen settles with DOJ over questionable Aranesp marketing; FDA denies approval for Allergan's inhalable migraine drug; Lilly posts promising top-line data of new experimental diabetes treatment; J&J wins second hip trial
 
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising App Approval Clinical Trial Consumer COPD Corporate Reputation Diabetes DTC Earnings FDA Generic Generic Drugs Health Affairs iPad Marketing & Communications Merck Mobile Obesity Patent Cliff Patients Regulatory Wellness